Wang et al. confirmed that TIMP1 regulated metabolism in metastases by activating the PI3K/Akt pathway and found TIMP1 as a potential biomarker for understanding lung adenocarcinoma pathogenesis [38]. This evidence concerns the gene AKT1 and lung adenocarcinoma.